Skip to main content

Federal Employees Health Benefits Program: Enrollee Cost Sharing for Selected Specialty Prescription Drugs

GAO-09-517R Published: Apr 30, 2009. Publicly Released: Jun 01, 2009.
Jump To:
Skip to Highlights

Highlights

Recent increases in prescription drug costs have been fueled in part by the high and rising cost of specialty prescription drugs. Specialty prescription drugs are typically used to treat chronic or life-threatening conditions, such as multiple sclerosis and cancer, for which few other treatment options exist. The drugs typically have few competitors or generic alternatives and may require frequent dosage adjustment, special storage, patient education, or special methods of administration, such as by injection. Costs for specialty prescription drugs are usually high, typically ranging from $1,200 to $40,000 for a 30-day supply. Health plans--including those participating in the Federal Employees Health Benefits Program (FEHBP), which covers nearly 8 million federal employees, dependents, and retirees-- provide coverage for many specialty drugs. Enrollees may be required to pay a portion of specialty drug costs through a copayment--a flat dollar amount--or coinsurance--a percentage share of the drug's actual costs. To manage the high and rising costs of these drugs, some health plans have begun to require enrollees to contribute a greater share of their costs, such as by increasing the use of coinsurance. Congress asked us to examine the costs that FEHBP enrollees may incur for specialty prescription drugs. In this report we describe cost-sharing requirements and limits for specialty drugs covered by FEHBP plans.

Full Report

Office of Public Affairs

Topics

Cost analysisCost sharing (finance)Deductibles and CoinsuranceEmployee medical benefitsFederal employeesHealth care cost controlHealth care costsPharmaceutical industryPrescription drugsCost controlData collectionGeneric drugsRequirements definitionCost growth